Abstract
Introduction . Up to 30% of patients with acute myeloid leukemia (AML) have a mutation in the FLT3 receptor. Molecular targets have acquired a signifi......
小提示：本篇文献需要登录阅读全文，点击跳转登录
Full Text Link
